Clinical Trials on Recurrent Pregnancy Loss Without Current Pregnancy in United Kingdom

Total 1073 results

Nora Therapeutics, Inc.

Unknown

A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL) (RESPONSE)

Recurrent Miscarriage | Recurrent Pregnancy Loss

United Kingdom
University of Utah
Intermountain Health Care, Inc.

Withdrawn

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Miscarriage | Recurrent Pregnancy Loss

United States
Stanford University
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility

Unexplained Infertility | Recurrent Pregnancy Loss

United States
Walter Reed National Military Medical Center

Recruiting

Tender Loving Care for Recurrent Pregnancy Loss

Recurrent Pregnancy Loss

United States
Yale University
Johns Hopkins University; University of Colorado, Denver; Eunice Kennedy Shriver... and other collaborators

Recruiting

Genomic Predictors of Recurrent Pregnancy Loss (GPRPL)

Recurrent Pregnancy Loss

United States
Stanford University

Terminated

Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss

Overweight | Miscarriage | Obese | Recurrent Pregnancy Loss

United States
Imperial College London

Completed

Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

Recurrent Miscarriages

United Kingdom
University of Birmingham
Tommy's

Completed

The Role of Hydrosalpinx in Recurrent Miscarriage

Miscarriage, Recurrent | Abortion, Spontaneous | Hydrosalpinx

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
Cambridge University Hospitals NHS Foundation Trust; University of Southampton and other collaborators

Completed

Antibiotic Prophylaxis for Clean Intermittent Catheterisation (AnTIC)

Urinary Tract Infections, Recurrent

United Kingdom
Lawrence Engmann
The Center for Advanced Reproductive Services, P.C.; ZyMot Fertility

Active, not recruiting

Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates

Infertility | Recurrent Pregnancy Loss

United States
Reprogenetics
Main Line Fertility Center

Unknown

Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis

Infertility | Recurrent Pregnancy Loss

United States
Ferrer inCode, S.L.
Instituto Valenciano de Infertilidad, IVI VALENCIA; Instituto de Investigacion... and other collaborators

Completed

Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score (TiC-RPL)

Miscarriage, Recurrent

Spain, United Kingdom
Reprogenetics
McGill University; Yale University; Reprogenetics, Livingston, NJ; Long Island... and other collaborators

Suspended

Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH

Infertility | Recurrent Pregnancy Loss

United States
King's College Hospital NHS Trust

Recruiting

RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women With Recurrent Urinary Tract Infections (UTIEXTERMINATE)

Recurrent Urinary Tract Infection | Genitourinary Syndrome of Menopause

United Kingdom
University of Chicago
Sunnybrook Health Sciences Centre; University of British Columbia; University... and other collaborators

Completed

Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage

Abortion, Habitual | Miscarriage, Recurrent

United States
CyberKnife Centers of San Diego

Unknown

CyberKnife Radiosurgery for Locally Recurrent Prostate CA

Recurrent Prostate Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma

United States
Nationwide Children's Hospital
Thrasher Research Fund

Completed

Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children (Nissle 1917)

Catheter-Related Infections | Recurrent UTIs

United States
NorthShore University HealthSystem

Completed

Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs

Urinary Tract Infections, Recurrent

United States
University Hospital Southampton NHS Foundation...

Completed

Feasibility Study of a Coping Intervention for Recurrent Miscarriage

Miscarriage

United Kingdom
University Hospitals Coventry and Warwickshire...
University of Warwick

Completed

Sim (Scratch in Miscarriage) Study (SiM)

Recurrent Miscarriage

United Kingdom
University of California, Irvine

Completed

Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections

Recurrent Urinary Tract Infection

United States
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer (EXCERPT)

Prostate Cancer Recurrent

United Kingdom
University of Oxford
Finox Biotech

Unknown

The PIP Study - Pre- IVF Immune Profiling Study (PIP)

Recurrent Implantation Failure | Sub-fertility

United Kingdom
Ann & Robert H Lurie Children's Hospital of Chicago

Recruiting

A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections

Recurrent Uti

United States
Johns Hopkins University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Enrolling by invitation

Preventing Recurrent UTI With Vaginal Estrogen (PRUVE)

Urinary Tract Infections | Recurrent Urinary Tract Infection | Cystitis Recurrent

United States
Matrix Biomed, Inc.
Prostate Oncology Specialists

Not yet recruiting

MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer

Prostate Cancer Recurrent | Biochemical Recurrent Prostate Cancer

United States
Haider Mahdi
GlaxoSmithKline; Zenith Epigenetics

Recruiting

ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors

Ovarian Cancer | Recurrent Solid Tumors

United States
University of California, San Diego
NYU Langone Health; American Urogynecologic Society

Completed

Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women (VESPR)

Recurrent Urinary Tract Infection

United States
University of Washington
National Cancer Institute (NCI); United States Department of Defense

Recruiting

Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
University of Washington
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Completed

Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Terminated

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Northwestern University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astex Pharmaceuticals...

Completed

Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
University of Wisconsin, Madison
National Institutes of Health (NIH)

Completed

Vaccine for Recurrent Urinary Tract Infections in Women

Recurrent Urinary Tract Infections in Women

United States
Imperial College Healthcare NHS Trust

Completed

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer (ProGem2)

Recurrent Ovarian Cancer

United Kingdom
Jonsson Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Sarcoma

United States
University of California, Irvine

Recruiting

Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections

Recurrent Urinary Tract Infection | Hypoestrogenism

United States
University of Oklahoma

Recruiting

Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)

Recurrent Urinary Tract Infections

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
University of Washington
National Cancer Institute (NCI)

Recruiting

Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
University of Chicago
University of British Columbia

Completed

Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy

Abortion, Habitual | Recurrent Pregnancy Loss | Fetal Demise | Antiphospholipid Antibodies | Inherited Thrombophilia

United States
David M. Schuster, MD

Completed

FACBC for Recurrent Prostate Cancer

Recurrent Prostate Cancer

United States
Loyola University

Recruiting

BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy (BEACON)

Prostate Cancer - Recurrent

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Active, not recruiting

Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation

Recurrent Prostate Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States

Clinical Trials on Recurrent Pregnancy Loss Without Current Pregnancy in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations